Join us in Denver and online for AAIC 2021, where the world’s leading basic scientists, clinical researchers, early career investigators, clinicians and the care research community will share breaking research discoveries that will lead to methods of prevention and treatment and improvements in diagnosis for Alzheimer’s disease. AAIC 2021 will follow COVID-19 guidance per the...
As both consumers and HCPs try to adapt to life during COVID – while aiming towards a better future – the demand for detailed and accessible scientific information has never been greater. Now more than ever, your medical affairs team must upskill and stay relevant as consumers use new channels to absorb information. DGE’s 4th...
In 2021, Berkeley Lab's 90th year, we're celebrating past achievements and imagining tomorrow's solutions. As part of this celebration we are highlighting our facilities like never before! In this pre-scheduled, live, interactive, presentation by Lab staff and scientists you will learn about the Joint Genome Institute. The mission of the U.S. Department of Energy (DOE) Joint Genome...
Miss being able to network with colleagues in the life science industry? We have you covered with the best virtual networking experience through Grapevine Network's networking platform. Connect with life science colleagues from all over the world. BioXchange has gone virtual to allow the best online opportunity to interact with individuals from throughout the life...
This lung therapeutic symposium intends to bring advancement and cross-functional collaboration at the interface of discovery and development in the inhalation space. The symposium will give insight into the underlying biology of lung targets, which may open potential avenues for new biomarkers and respiratory therapeutics. It will also outline the differences in pharmacokinetic and in-vitro...
Join Biocom California, LA for a conversation with life science entrepreneurs, investors, and thought leaders from the Pasadena and San Gabriel Valley area as we highlight bioscience innovation, economic and research developments and expansion in this important ‘microcluster.’ Speakers: Opening Remarks – Senator Anthony Portantino, of the 25th Senate District Panel Discussion – Andreas Gille,...
Join us for this FREE, virtual event! Randall Hyer, MD, PhD, MPH Senior Vice President at Moderna Therapeutics, Inc. will be presenting on the topic "The Beginning and End of COVID-19." This event is free of charge but pre-registration is required.
Non-dilutive funding refers to financing that does not require selling or giving away equity to raise capital. Therefore, it does not result in the dilution of the existing company owners. Examples include commercial loans, profit-sharing arrangements, foundation grants, and government SBIR & STTR grants. This meeting will focus primarily on the latter type of non-dilutive...
Biocom California and NIRI San Diego invite you to join us on Tuesday, August 3rd for an in-person event geared towards CFOs and Investor Relations professionals within the life science industry, as we welcome back Chief Economist of Nasdaq, Inc., Phil Mackintosh. Phil's team is responsible for a variety of research and analysis to improve...
It wasn’t long ago when we first heard about the promise of stem cells. They were the wave of the future. With stem cells we’d be able to cure disease, repair organs and test new drugs for effectiveness before introducing them into humans. Has the promise of stem cells been overstated? No. The promise has...
Join other SF Bay biotech professionals for a free virtual tour As a biotech professional in the San Francisco Bay area, you're invited to a free virtual tour of Explora BioLabs' newest OnDemand vivarium location in Alameda. Biotech experts and researchers know Explora BioLabs as the nation's largest provider of preclinical, Ph.D.-backed contract vivarium facilities and services—what...
The last few years has seen major advancements in cancer treatment through immunotherapy. This symposium aims to provide a comprehensive overview of the emerging concepts in cancer immunotherapy from the latest biologic insights in academia and the latest clinical data for approved and investigational immuno-oncology agents from key biotech and pharmaceutical companies. We will discuss...
